Advanced Biodesign
Latest round
- Series D
Last raised
- Mar 2023
Total raised
- $26M
Investors
- 1
About Advanced Biodesign
Advanced Biodesign is dedicated to the research and development of advanced cancer therapies. The company is headquartered in France and has been actively involved in the oncology space since its inception. The founder of the company has a notable history in biotechnology, although specific details of previous enterprises are not disclosed.Advanced BioDesign specializes in the development of innovative therapies aimed at overcoming drug resistance in cancer treatment, particularly for patients with elevated levels of ALDH1. The lead product, ABD-3001, is a small-molecule inhibitor targeting the ALDH family of enzymes, currently in the initial stages of clinical development and being evaluated for efficacy across various malignancies, including acute myeloid leukemia, non-small cell lung cancer, and melanoma.20.71 million to support the clinical development of its lead product, ABD-3001, and potentially expand its offerings. The company aims to introduce new products in the oncology sector and intends to expand its market reach into additional territories within Europe and North America by 2025, focusing on enhancing access to its innovative therapies.
Who invested in Advanced Biodesign
1 investor across 11 rounds
See all investors in Advanced Biodesign
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Mar 1, 2023
Amount
$1.9M
Investors
Series D
Sep 2, 2021
Amount
$7.7M
Investors
Series D
Mar 20, 2020
Amount
$8.3M
Investors
Series D
Jul 18, 2018
Amount
$2.4M
Investors
Series D
Dec 27, 2017
Amount
$0.7M
Investors
Series D
Jan 18, 2017
Amount
$1.9M
Investors
Series B
Jul 22, 2016
Amount
$0.1M
Investors
Series B
Mar 31, 2016
Amount
$1M
Investors
Series B
Apr 16, 2015
Amount
$0.8M
Investors
Series B
Aug 5, 2014
Amount
$0.9M
Investors
Series B
Jan 28, 2014
Amount
$0.5M
Investors
Questions about Advanced Biodesign
Who invested in Advanced Biodesign?
Advanced Biodesign has 1 investor on record across 11 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Advanced Biodesign raised?
Advanced Biodesign has raised 11 venture rounds. Sign up free to see how much each round raised and the total.
When did Advanced Biodesign last raise money?
Advanced Biodesign's most recent round on record is a Series D, in Mar 2023.
What does Advanced Biodesign do?
Advanced Biodesign is dedicated to the research and development of advanced cancer therapies.
Where is Advanced Biodesign headquartered?
Advanced Biodesign is headquartered in France.
Which VCs invest in companies like Advanced Biodesign?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Advanced Biodesign's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Advanced Biodesign? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.